Bvf Gp Holdings Llc - Net Worth and Insider Trading
Bvf Gp Holdings Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bvf Gp Holdings Llc owns 25 companies in total, including Five Prime Therapeutics Inc (FPRX) , Eledon Pharmaceuticals Inc (ELDN) , and XOMA Royalty Corp (XOMA) among others .
Click here to see the complete history of Bvf Gp Holdings Llc’s form 4 insider trades.
Insider Ownership Summary of Bvf Gp Holdings Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2020-10-06 | 10 percent owner |
| ELDN | Eledon Pharmaceuticals Inc | 2020-10-01 | 10 percent owner |
| XOMA | XOMA Royalty Corp | 2020-03-13 | 10 percent owner |
 | | 2020-06-01 | 10 percent owner |
| | 2021-06-16 | other: See Explanation of Responses |
| | 2020-08-18 | 10 percent owner |
| | 2020-06-18 | other: See Explanation of Responses |
| | 2020-03-02 | 10 percent owner |
| | 2020-03-13 | 10 percent owner |
| | 2020-11-12 | other: See Explanation of Responses |
| | 2021-01-22 | 10 percent owner |
| | 2020-10-30 | 10 percent owner |
| | 2020-12-18 | 10 percent owner |
| | 2022-01-25 | 10 percent owner |
| | 2021-04-22 | other: See Explanation of Responses |
| | 2020-11-18 | 10 percent owner |
| | 2021-12-31 | 10 percent owner |
| | 2021-10-28 | 10 percent owner |
| | 2022-04-05 | director & 10 percent owner |
| | 2022-06-16 | 10 percent owner |
| | 2022-07-11 | 10 percent owner |
| | 2022-12-19 | other: See Explanation of Responses |
| | 2023-02-03 | 10 percent owner |
| | 2023-05-11 | 10 percent owner |
| | 2023-11-02 | 10 percent owner |
Bvf Gp Holdings Llc Trading Performance
Bvf Gp Holdings Llc Ownership Network
Bvf Gp Holdings Llc Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Inc/il .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XOMA Royalty Corp do?
Who are the key executives at XOMA Royalty Corp?
Bvf Gp Holdings Llc is the 10 percent owner of XOMA Royalty Corp. Other key executives at XOMA Royalty Corp include Chief Financial Officer Thomas M. Burns , director & Interim CEO Owen Hughes , and Chief Investment Officer Bradley Sitko .
XOMA Royalty Corp (XOMA) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in XOMA Royalty Corp (XOMA). Other recent insider transactions involving XOMA Royalty Corp (XOMA) include a net sale of 18,381 shares made by Owen Hughes , a net purchase of 3,250 shares made by Bradley Sitko , and a net sale of 9,775 shares made by Thomas M. Burns .
In summary, during the past 3 months, insiders sold 31,656 shares of XOMA Royalty Corp (XOMA) in total and bought 0 shares, with a net sale of 31,656 shares. During the past 18 months, 31,656 shares of XOMA Royalty Corp (XOMA) were sold and 6,750 shares were bought by its insiders, resulting in a net sale of 24,906 shares.
XOMA Royalty Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Royalty Corp Insider Transactions
- Download to Excel(.xls)
What does Merus NV do?
Who are the key executives at Merus NV?
Bvf Gp Holdings Llc is the 10 percent owner of Merus NV. Other key executives at Merus NV include Chief Accounting Officer Harry Shuman , EVP & General Counsel Peter B. Silverman , and director & President & CEO & PFO Sven Ante Lundberg .
Merus NV (MRUS) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Merus NV (MRUS). Other recent insider transactions involving Merus NV (MRUS) include a net sale of 20,815 shares made by Harry Shuman , and a net sale of 94,386 shares made by Peter B. Silverman .
In summary, during the past 3 months, insiders sold 0 shares of Merus NV (MRUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 115,201 shares of Merus NV (MRUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 115,201 shares.
Merus NV (MRUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merus NV Insider Transactions
- Download to Excel(.xls)
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Bvf Gp Holdings Llc is the other: See Explanation of Responses of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .
Kymera Therapeutics Inc (KYMR) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .
In summary, during the past 3 months, insiders sold 13,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 13,500 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.
Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does IDEAYA Biosciences Inc do?
Who are the key executives at IDEAYA Biosciences Inc?
Bvf Gp Holdings Llc is the other: See Explanation of Responses of IDEAYA Biosciences Inc. Other key executives at IDEAYA Biosciences Inc include SVP & Chief Scientific Officer Michael Anthony White , director & President and CEO Yujiro S Hata , and See Remarks Briseno Andres Ruiz .
IDEAYA Biosciences Inc (IDYA) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net sale of 38,470 shares made by Jason Throne , a net sale of 425,000 shares made by Yujiro S Hata , and a net sale of 10,000 shares made by Briseno Andres Ruiz .
In summary, during the past 3 months, insiders sold 0 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 514,470 shares of IDEAYA Biosciences Inc (IDYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,470 shares.
IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEAYA Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Bvf Gp Holdings Llc is the 10 percent owner of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
- Download to Excel(.xls)
What does XOMA Royalty Corp do?
Who are the key executives at XOMA Royalty Corp?
Bvf Gp Holdings Llc is the 10 percent owner of XOMA Royalty Corp. Other key executives at XOMA Royalty Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and 10 percent owner Bvf I Gp Llc .
XOMA Royalty Corp (XOMAO.PFD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XOMA Royalty Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Royalty Corp Insider Transactions
- Download to Excel(.xls)
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Bvf Gp Holdings Llc is the other: See Explanation of Responses of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 343,500 shares made by Robert I Blum , a net sale of 205,949 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 90,420 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 90,420 shares. During the past 18 months, 652,527 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 652,527 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
- Download to Excel(.xls)
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .
Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .
GlycoMimetics Inc (GLYC) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 17,500 shares made by Brian M. Hahn .
In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,271,499 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,883,596 shares.
GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 0 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 668 shares made by Daniel Calkins , a net sale of 20,888 shares made by Robert E. Gagnon , and a net sale of 6,617 shares made by Dan Paterson .
In summary, during the past 3 months, insiders sold 2,695 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,695 shares. During the past 18 months, 33,122 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,122 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Bvf Gp Holdings Llc is the other: See Explanation of Responses of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang ,
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 173,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 1,198,445 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Bvf Gp Holdings Llc is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & Chief Technology Officer Cyrus Harmon , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 1,710,000 shares made by G. Walmsley Graham .
In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,223,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 2,977,142 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 102,471 shares made by Jennifer Michaelson , a net sale of 4,962 shares made by Jeffrey Trigilio , and a net sale of 120,000 shares made by Savill Corrine .
In summary, during the past 3 months, insiders sold 16,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 16,000 shares. During the past 18 months, 237,078 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 237,078 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , President and CEO Lloyd Mitchell Segal , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc (RPTX) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .
In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.
Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Bvf Gp Holdings Llc is the director & 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & 10 percent owner Biotechnology Value Fund L P , director & Chief Executive Officer Santos Da Silva Jorge , and Chief Scientific Officer Kristian Reich .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 802,051 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .
In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 802,051 shares were bought by its insiders, resulting in a net sale of 1,853,689 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net sale of 540,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 500 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ESSA Pharma Inc do?
Who are the key executives at ESSA Pharma Inc?
Bvf Gp Holdings Llc is the 10 percent owner of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include 10 percent owner Biotech Growth N V , Chief Operating Officer Peter Virsik , and director & Chief Executive Officer David Ross Parkinson .
ESSA Pharma Inc (EPIX) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in ESSA Pharma Inc (EPIX). Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 81,945 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net sale of 7,879,583 shares made by Biotech Growth N V .
In summary, during the past 3 months, insiders sold 7,883,053 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 7,883,053 shares. During the past 18 months, 7,961,528 shares of ESSA Pharma Inc (EPIX) were sold and 108,953 shares were bought by its insiders, resulting in a net sale of 7,852,575 shares.
ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
ESSA Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Third Harmonic Bio Inc do?
Who are the key executives at Third Harmonic Bio Inc?
Bvf Gp Holdings Llc is the other: See Explanation of Responses of Third Harmonic Bio Inc. Other key executives at Third Harmonic Bio Inc include Chief Medical Officer Edward R. Conner , other: See Explanation of Responses Biotechnology Value Fund L P , and Chief Administrative Officer Julie Person .
Third Harmonic Bio Inc (THRD) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,970 shares made by Julie Person , a net sale of 14,370 shares made by Edward R. Conner , and a net sale of 25,114 shares made by .
In summary, during the past 3 months, insiders sold 1,019,580 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 1,019,580 shares. During the past 18 months, 1,107,234 shares of Third Harmonic Bio Inc (THRD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,107,234 shares.
Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Third Harmonic Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Structure Therapeutics Inc do?
Who are the key executives at Structure Therapeutics Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Structure Therapeutics Inc. Other key executives at Structure Therapeutics Inc include other: See Explanation of Responses Biotechnology Value Fund L P , other: See Explanation of Responses Bvf Ii Gp Llc , and other: See Explanation of Responses Bvf I Gp Llc .
Structure Therapeutics Inc (GPCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc (GPCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc (GPCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Structure Therapeutics Inc (GPCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Structure Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Bvf Gp Holdings Llc is the 10 percent owner of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include other: See Explanation of Responses Bvf Ii Gp Llc , 10 percent owner Bvf I Gp Llc , and Chief Development Officer Shane Olwill .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Bvf Gp Holdings Llc is the 10 percent owner of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and other: See Explanation of Responses Bvf Ii Gp Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
Over the past 18 months, Bvf Gp Holdings Llc made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xls)
Bvf Gp Holdings Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Bvf Gp Holdings Llc. You might contact Bvf Gp Holdings Llc via mailing address: 44 Montgomery St., 40th Floor, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
